Literature DB >> 7779569

Effects of selenium supplementation on thyroid hormone metabolism in phenylketonuria subjects on a phenylalanine restricted diet.

M Calomme1, J Vanderpas, B François, M Van Caillie-Bertrand, N Vanovervelt, C Van Hoorebeke, D Vanden Berghe.   

Abstract

Type I 5'-deiodinase was recently characterized as a selenocysteine-containing enzyme in humans and other mammals. Up to now, the effect of selenium (Se) supplementation on thyroid hormone metabolism in humans has only been reported in the very peculiar nutritional environment of Central Africa, where combined severe iodine and Se deficiency occurs. In this study, a group of phenylketonuria subjects with a low selenium status, but a normal iodine intake were supplemented with selenium to investigate changes in their thyroid hormone metabolism. After 3 wk of selenium supplementation (1 microgram/kg/d), both the concentrations of the prohormone thyroxine (T4) and the metabolic inactive reverse triiodothyronine (rT3) decreased significantly. Clinically, the phenylketonuria subjects remained euthyroid before and after selenium supplementation. The individual changes of plasma Se and glutathione peroxidase activity were closely associated with individual changes of plasma T4 and rT3.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7779569     DOI: 10.1007/BF02790137

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  6 in total

1.  Identification of type I iodothyronine 5'-deiodinase as a selenoenzyme.

Authors:  D Behne; A Kyriakopoulos; H Meinhold; J Köhrle
Journal:  Biochem Biophys Res Commun       Date:  1990-12-31       Impact factor: 3.575

2.  Direct selenium determination in human whole blood by graphite furnace atomic absorption spectrometry with deuterium correction using a L'vov-platform, a Pd/Mg matrix modification and appropriate dilution.

Authors:  R Van Cauwenbergh; H Robberecht; P Van Dael; H Deelstra
Journal:  J Trace Elem Electrolytes Health Dis       Date:  1990-06

3.  Effect of selenium supplementation in hypothyroid subjects of an iodine and selenium deficient area: the possible danger of indiscriminate supplementation of iodine-deficient subjects with selenium.

Authors:  B Contempre; J E Dumont; B Ngo; C H Thilly; A T Diplock; J Vanderpas
Journal:  J Clin Endocrinol Metab       Date:  1991-07       Impact factor: 5.958

4.  Cloning and in vitro expression of the human selenoprotein, type I iodothyronine deiodinase.

Authors:  S J Mandel; M J Berry; J D Kieffer; J W Harney; R L Warne; P R Larsen
Journal:  J Clin Endocrinol Metab       Date:  1992-10       Impact factor: 5.958

5.  Effects of selenium deficiency on thyroid hormone economy in rats.

Authors:  J P Chanoine; M Safran; A P Farwell; S Dubord; S Alex; S Stone; J R Arthur; L E Braverman; J L Leonard
Journal:  Endocrinology       Date:  1992-10       Impact factor: 4.736

6.  Seleno-lactobacillus. An organic selenium source.

Authors:  M Calomme; J Hu; K Van den Branden; D A Vanden Berghe
Journal:  Biol Trace Elem Res       Date:  1995 Jan-Mar       Impact factor: 3.738

  6 in total
  3 in total

1.  The role of selenium in iodine metabolism in children with goiter.

Authors:  P Zagrodzki; H Szmigiel; R Ratajczak; Z Szybinski; Z Zachwieja
Journal:  Environ Health Perspect       Date:  2000-01       Impact factor: 9.031

2.  Nutritional status of patients with phenylketonuria in Japan.

Authors:  Yoshiyuki Okano; Toshikazu Hattori; Hiroki Fujimoto; Kaori Noi; Miki Okamoto; Toshiaki Watanabe; Ryoko Watanabe; Rika Fujii; Tomoko Tamaoki
Journal:  Mol Genet Metab Rep       Date:  2016-08-20

Review 3.  Supplementation of Micronutrient Selenium in Metabolic Diseases: Its Role as an Antioxidant.

Authors:  Ning Wang; Hor-Yue Tan; Sha Li; Yu Xu; Wei Guo; Yibin Feng
Journal:  Oxid Med Cell Longev       Date:  2017-12-26       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.